Article
Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
Molecular genetics and metabolism - 1 Aug 2018
Khoja Suhail, Nitzahn Matt, Hermann Kip, Truong Brian, Borzone Roberta, Willis Brandon, Rudd Mitchell, Palmer Donna J, Ng Philip, Brunetti-Pierri Nicola, Lipshutz Gerald S
Abstract excerpt
Carbamoyl phosphate synthetase 1 (CPS1) is a urea cycle enzyme that forms carbamoyl phosphate from bicarbonate, ammonia and ATP. Bi-allelic mutations of the CPS1 gene result in a urea cycle disorder presenting with hyperammonemia, often with reduced citrulline, and without orotic aciduria. CPS1 deficiency is particularly challenging to treat and lack of early recognition typically results in early neonatal death....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
